This antibody targets LPLUNC1 (C20orf114), a protein naturally secreted in the airway, and is of the IgG1 isotype. It was developed using recombinant human LPLUNC1 as the immunogen and has been validated for several applications such as Western blot, ELISA, and immunostaining in human samples. The approach leverages in vitro studies to ascertain its potential for modulating respiratory infections by addressing a key component present in the natural airway defense system.